Response to Letter to the Editor: Comment on Bone Marrow Mesenchymal Stem Cells for Heart Failure Treatment: A Systematic Review and Meta-Analysis

We thank Sun and Gu [1] (this issue) for their interest in our recently published manuscript entitled “Bone Marrow Mesenchymal Stem Cells (BM-MSCs) for Heart Failure Treatment: A Systematic Review and Meta-Analysis” [2]. While commending the clinical significance of our findings vis-a-vis the effectiveness of BM-MSCs in treating heart failure patients, using left ventricular ejection fraction (L VEF) and six-minute walk distance (6MWD) as primary endpoints, the authors have extended a couple of queries which warrant our response.
Source: Heart, Lung and Circulation - Category: Cardiology Authors: Tags: Letter to the Editor Source Type: research